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ABSTRACT Neurotrophins such as nerve growth factor (NGF) may be useful for treating diseases in the central nervous
system; our ability to harness the potential therapeutic beneﬁt of NGF is directly related to our understanding of the fate of
exogenously supplied factors in brain tissue. We utilized multiphoton microscopy to quantify the dynamic behavior of NGF in
coronal, 400-mm thick, fresh rat brain tissue slices. We administered a solution containing bioactive rhodamine nerve growth
factor conjugate via pressure injection and monitored the dispersion in the striatal region of the coronal slices. Multiphoton
microscopy facilitated repeated imaging deep (;200 mm) into tissue slices with minimal photodamage of tissue and
photobleaching of label. The pressure injection paradigm approximated diffusion from a point source, and we therefore used the
corresponding solution to the diffusion equation to estimate an apparent diffusion coefﬁcient in brain tissue (Db(348C)) of 2.756
0.24 3 107 cm2/s (average 6 SE). In contrast, we determined a corresponding free diffusion coefﬁcient in buffered solution
(Df(348C)) of 12.6 6 0.9 3 10
7 cm2/s using multiphoton ﬂuorescence photobleaching recovery. The tortuosity, deﬁned as the
square root of the ratio of Df to Db, was 2.14 and moderate in magnitude.
INTRODUCTION
Nerve growth factor (NGF) is a 130-kD protein homodimer
with each monomer comprised of three subunits, a, b, and g
(Thoenen and Barde, 1980). The 26-kD b-subunit is
responsible for the bioactivity of NGF. Exogenous supply
of NGF to the brains of animals clearly demonstrates the
capability of the neurotrophin to rescue septal cholinergic
cells from both injury-induced (Gage et al., 1988) and
spontaneous, age-related (Fischer et al., 1987) degeneration,
giving rise to promise that NGF might be a potential
treatment for Alzheimer’s disease. Because NGF does not
appreciably cross the blood-brain barrier and plasma half-
lives are short, proposed treatment strategies involve direct
administration of NGF to diseased brain tissue in Al-
zheimer’s patients (Tuszynski and Kordower, 1999). As with
normal cells, which secrete growth factors to convey
information, so too in diseased tissue we utilize a source of
diffusible factor to convey a trophic signal to degenerating
neurons. A clear understanding of the transport phenomena
involved is of paramount importance to ensure that NGF
rescues diseased cells from degeneration while interfering
minimally with normal tissue.
Much of what we know today about NGF transport in
tissue is the result of a commonly used methodology: NGF is
administered to the brain of an animal, the animal is sacri-
ﬁced, the brain is sectioned, and the protein is detected
generally through autoradiography or immunohistochemis-
try (Krewson et al., 1995; Morse et al., 1993; Yan et al.,
1994). Although such a procedure is useful to learn end-
point information, it is extremely difﬁcult to use this method-
ology to get information about the dynamic behavior of the
molecule in tissue. The distribution at each time point is
obtained from an individual animal; the effect of time is
confounded by variability between experiments and animals.
Furthermore, the distribution at time points well after the
initial administration is a result of simultaneous, compet-
ing processes that serve to disperse the protein (‘‘transport
processes’’), and degrade and eliminate (‘‘elimination mech-
anisms’’) it from the tissue (Radomsky et al., 1990). Whether
NGF supply is from a controlled-release polymer (Krewson
and Saltzman, 1996), an infusion pump (Morse et al., 1993),
or cells genetically modiﬁed to secrete NGF (Tuszynski et al.,
1996), any ﬁnal distribution determined from longtime, static
snapshots is a consequence of both transport and elimination
mechanisms. We must be able to account for both accurately
to propose rational improvements in formulation design.
We studied the diffusive spread of a bioactive, rhodamine-
bNGF conjugate (RNGF) in the striatal region of rat brain
tissue slices over the course of 0.5–2.0 min using multi-
photon microscopy (MPM). The use of brain tissue slices
allowed imaging of the striatum—a uniform, approximately
spherical domain deep within the rat brain (Paxinos and
Watson, 1986). Two-photon imaging simpliﬁed our study;
out-of-focus ﬂuorescence did not blur the recorded image,
and we could repeatedly image deep (;200 mm) within the
slice with both minimal photodamage to tissue and photo-
bleaching of label. We selected speciﬁc timescales for deliv-
ery of agent and monitoring of dispersion to facilitate the
subsequent analysis. We administered small, rapidly deliv-
ered (0.25–1.0 s) volumes of tracer from a micropipette, and
monitored the dispersion for 20 s to 2.0 min. The span of
time over which we monitored dispersion was much less
than any previous estimates of NGF half-life in the brain (30
min (Krewson et al., 1995)); this further simpliﬁed the anal-
ysis because an elimination mechanism was not needed in
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the model. We modeled the dispersion of RNGF as diffusion
after administration from a point source (‘‘point-source dif-
fusion’’), for which the solution is well known (Berg, 1983).
By considering a diffusion-only system, we could make
statements concerning the relative ease of diffusive RNGF
transport.
Cellular membranes and macromolecules of the extracel-
lular space (ECS) act as physical barriers that increase the
effective path length for diffusion (Radomsky et al., 1990;
Rice and Nicholson, 1991; Sykova, 1997). Therefore, we
expect a disparity between the free diffusion coefﬁcient in
solution (Df), and the apparent diffusion coefﬁcient in tissue
(Db). The ratio of Df to Db is deﬁned as the square of the
tortuosity (t2); tortuosity increases as a molecule experiences
greater difﬁculty in navigating the ECS. Other factors act
to further impede diffusive transport in tissue, including
molecular shape and size (Pluen et al., 1999; Prokopova-
Kubinova et al., 2001), binding (Berk et al., 1997), and
charge interactions (Nugent and Jain, 1984). The complex-
ities of transport through the ECS hamper efforts at an
accurate, predictive model for t, necessitating robust, ac-
curate techniques for experimental determination of Db and
Df. The well-deﬁned excitation volume characteristic of
MPM not only assisted us in our efforts to determine Db, but
also facilitated determination of Df via multiphoton ﬂuores-
cence photobleaching recovery (MPFPR) (Brown et al.,
1999; Zipfel and Webb, 2001). Brieﬂy, in this technique the
laser intensity was modulated to ﬁrst photobleach and then
monitor the same subvolume of solution containing RNGF.
Recovery of the signal was due to the diffusion of un-
bleached molecules back into the previously bleached vol-
ume. We obtained Df by ﬁtting the recovery data to the
model described in Brown et al. (1999).
MATERIALS AND METHODS
Our study was comprised of both a trial to validate our new method and an
effort to estimate transport constants for RNGF. We selected a FITC-con-
jugated 70 kD dextran (Molecular Probes, Eugene, OR) for our validation
trial because there are literature estimates of Db for 70 kD dextran adminis-
tered to the cortex of rats (Nicholson and Tao, 1993). Unless otherwise
indicated, we utilized the Matlab (Mathworks, Natick, MA) environment for
ﬁtting models to data, and JMP (SAS Institute, Cary, NC) for all hypothesis
testing and cluster analysis. We employedMatlab’s ‘‘fmins’’ routine to mini-
mize sum of squared errors between data and given nonlinear models, and the
‘‘regress’’ algorithm for linear regression analysis.
RNGF conjugate
A bioactive RNGF conjugate was prepared based upon a procedure by Levi
(Levi et al., 1980). Murine bNGF (Harlan, Indianapolis, IN) at a concen-
tration of 2 mg/ml in phosphate buffered saline (pH 7.2 PBS; 0.1 M sodium
phosphate, 0.15 M sodium chloride) was reacted with cystamine (Sigma, St.
Louis, MO) and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide, hydro-
chloride (EDAC; Molecular Probes) at 10 and 50 times molar excess over
NGF, respectively, for 2 h at room temperature. After an overnight dialysis
against PBS at 48C, 1.43 mM b-mercaptoethanol (Sigma) was added at 10
times molar excess over NGF. Tetramethylrhodamine-5-iodoacetamide
dihydroiodide (5-TMRIA; Molecular Probes) was added at 10 times molar
excess over the concentration of NGF and the mixture was reacted for 2 h at
room temperature with continual shaking. The mixture was dialyzed using
a 10-kD molecular weight cutoff dialysis cassette (Slide-A-Lyzer; Pierce,
Rockford, IL) at 48C against several complete changes of pH 7.4 PBS to
ensure removal of unreacted 5-TMRIA. Any precipitates that were formed
were removed by centrifugation at 14,000 3 g for a period of 10 min.
The RNGF was subjected to several biochemical and biological assays.
The concentration was determined using a total protein assay (Micro BCA;
Pierce), and the product purity was veriﬁed by SDS-PAGE with silver
staining. The RNGF was assayed for biological activity using the PC12 rat
pheochromocytoma cell line based on the neurite regeneration assay of
Greene (Greene et al., 1996). The PC12 cells were incubated with medium
(84% RPMI 1640, 10% heat-inactivated horse serum, 5% fetal bovine
serum, 1% penicillin/streptomycin; all from Invitrogen, Carlsbad, CA) sup-
plemented with 50 ng/ml NGF. At the end of one week, neurite-bearing cells
were harvested and washed repeatedly to facilitate removal of both neurites
and NGF. The cells were transferred to collagen-coated six-well plates, and
incubated with RNGF and NGF each at concentrations of 10, 100, and 500
ng/ml; three wells containing NGF-free medium were included for control.
Cells were imaged using an inverted phase contrast microscope (Diaphot;
Nikon, Tokyo, Japan) and the number of neurites with length of two cell
bodies or greater were noted for each condition.
Slice preparation
The following procedure for rat brain harvest was approved by the Cornell
University Animal Care and Use Committee. Male 35–40-day-old Fisher
rats (Charles River, Wilmington, MA) were deeply anesthetized using a 3.5
ml/kg intraperitoneal injection of a ketamine/xylazine solution, and decapi-
tated. Brains were quickly and carefully removed and chilled in ice-cold
artiﬁcial cerebral spinal ﬂuid (ACSF) with the following composition (in
mM) (Clancy et al., 2001): NaCl, 125; KCl, 3.5; MgCl2, 1.3; CaCl2, 2.5;
NaHCO3, 26; and glucose, 10; saturated with 95/5 O2/ CO2 pH 7.4. The
brains were blocked and glued to the chuck of an oscillating microtome
(752M Vibroslice, Campden Instruments, Ltd., UK) using cyanoacrylate
glue, and submerged in ice-cold ACSF that was continuously gassed with
95/5 O2/CO2. Four-hundred-micron thick coronal slices were obtained, and
slices of interest were maintained in a room-temperature holding chamber.
The custom-made chamber contained ACSF gassed with 95/5 O2/CO2
passed through a glass frit.
Pressure injection
After a 1-h period for slice equilibration, we transferred a slice of interest to
a custom-built chamber that rested upon the stage of the multiphoton
microscope. The chamber was comprised of a bath, a heating system, and
a mesh for holding the slices. The bath included a 10-cm glass Petri dish to
which tubing was afﬁxed with cyanoacrylate glue. Continuously gassed
ACSF was circulated through the chamber at a rate of ;1 ml/min with
a peristaltic pump. A heating system, comprised of a thermocouple, bench-
top controller (both from Omega Engineering, Stamford, CT), and bath
heater, maintained the bath at 348C. The bath heater was comprised of
a cartridge heater (Omega Engineering) placed in a custom-built, sub-
mersible heating ﬁn. Slices were suspended in the chamber between two
meshes comprised of nylon stockings. For the dextran validation trial, we
used an external rather than a submersible heater, and the bottom supporting
mesh was not used.
Injections were performed using prefabricated microcapillaries (Femto-
tips; Brinkmann Instruments, Westbury, NY) with a 0.5-mm inner diameter
and 1.0-mm outer diameter. Capillaries were loaded with test compound and
attached to the headstage of an Eppendorf Model 5242 pressure injector
system. Capillary tubes in the headstage were positioned using a Burleigh
micromanipulator (model PCS-5000) mounted on the microscope stage. The
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mass concentrations investigated were 1250 and 500 mg/ml in PBS for
dextran and RNGF, respectively. The microcapillary tip was lowered ;200
mm into the slice at a desired location within the striatum. We focused upon
the tip using MPM with a 103, 0.3 numerical aperture (NA) water-
immersion and a 43, 0.28 NA air-immersion lens for the RNGF and dextran
studies, respectively. The excitation wavelength was 850 nm for RNGF and
800 nm for FITC-dextran. The multiphoton microscope was comprised of
a Tsunami Ti:S laser pumped by a 10 W Millennia Nd:YVO4 laser (Spectra
Physics, Mountain View, CA), a modiﬁed MRC-600 scanbox (Bio-Rad
Microscience, Hemel Hempstead, UK), a Hamamatsu (Bridgewater, NJ)
GaAsP H7421-40 photomultiplier tube (PMT), and an upright, ﬁxed-stage
AX-70 Olympus microscope; additional details are available elsewhere
(Kloppenburg et al., 2000). The laser intensity was adjusted using
a ConOptics 350-80 electro-optic modulator to ensure that the intensity
data were within the linear range of the PMT. The modulator was also used
to blank the laser during scanner ﬂy-back to further reduce photobleaching
during image acquisition. A scan was performed immediately after inserting
the capillary to verify that no tracer entered the tissue before injection. The
pressure injector system was preprogrammed to allow a pressure pulse deli-
very lasting 0.25–1.0 s, and a volume of test compound was administered to
the slice. We collected from 20 to 60 images after pulse administration at
time intervals of 1–2 s depending upon the experiment.
For the dextran validation and the initial NGF experiments, the injector
capillary was left in the tissue for the duration of the recordings. The image
of the diffusing molecules was obstructed by the presence of the injector; by
removing the capillary, we could more readily analyze the entire area of
the diffusing injection. We executed a controlled experiment with RNGF in
which the only factor varied was the withdrawal of the injector cannula after
NGF administration, and did not note an effect of injector withdrawal upon
Db. We withdrew the injector immediately after injection for all subsequent
trials, and pooled data from trials with and without injector withdrawal.
MPFPR
The apparatus and procedure used for MPFPR measurements are described
in detail elsewhere (Brown et al., 1999; Zipfel and Webb, 2001). Brieﬂy, the
RNGF was loaded into deep-well slides and enclosed with number 1.5
coverslips. Although we used 500 mg/ml RNGF for Db determination, 5 mg/
ml RNGF (;190 nM) was used for MPFPR to help conserve conjugated
protein. Although this resulted in reduced signal to noise in the MPFPR
measurements, preliminary studies indicated no statistically signiﬁcant dif-
ference between Df estimates obtained with 500 mg/ml and 5 mg/ml RNGF.
The parked laser was focused within the sample using a 603, 1.2 NA water-
immersion lens. A 10-ms bleaching pulse was immediately followed by
acquisition of the ﬂuorescence recovery for 4 ms in 10-ms time bins. Due to
the low concentration of RNGF we used a high QE GaAsP PMT and 10,000
photobleach-monitor cycles per experiment, with a slow enough repeat rate
(50 Hz) to allow complete recovery of ﬂuorescence signal between cycles.
Analysis
Pressure injection methodology
The rapid delivery of RNGF from a small diameter oriﬁce allowed us to
approximate the dispersion as point-source diffusion (Berg, 1983). The









where C is the volume-averaged (Nicholson, 1985) concentration of NGF.
The solution to Eq. 1 in the point-source approximation is well known and
takes the form:
Cðr; tÞ ¼ Nð4pDbtÞ3=2
e
r2=4Db t; (2)
where N is the initial number of molecules administered. We used a slight
modiﬁcation of a two-step procedure to estimate Db (Nicholson and Tao,
1993). We executed a three-parameter ﬁt of the intensity data to Eq. 3 for
each of the extracted concentration proﬁles in the time series.
Iðr; tiÞ ¼ AieðrBiÞ
2
=Si : (3)
where I was the intensity at radial position r and time increment ti, and Ai, Bi,
and Si were ﬁt parameters. We included the parameter Bi to estimate the
center of the dispersing molecules. By comparison of Eq. 3 with exact
solution Eq. 2, Si is given by 4Dbti; for an ideal point source, a regression of
Si/4 upon ti gives Db as the slope with zero intercept. In practice, tracer
inﬁltrates the interstitial space during the injection (see Fig. 1 B). Although
the initial distribution of injected material deviates from an ideal point
source, the dispersing molecules behave as if they were released from a
‘‘virtual’’ point source at some time to before the actual injection (Nicholson
and Tao, 1993; Prokopova-Kubinova et al., 2001). This discrepancy results
in a negative time intercept in a regression of Si/4 upon ti; to explicitly
account for a nonzero intercept, Si takes the form 4Db(ti 1 to). The entire
optimization routine was repeated along each of two additional lines
constructed at consecutive 1208 intervals from the ﬁrst line.
MPFPR analysis
Fluorescence recovery data were ﬁt to the single component simple diffusion
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(4)
The 1/e2 beam dimensions vxy and vz were calculated as described in
Zipfel and Webb (2001) and the ﬁtting was carried out over the ﬁrst eight
terms of the summation. Values for the 1/e2 beam dimensions for both the
MPFPR and imaging studies described in the previous section are listed in
Table 1. We determined Df at 208C, and corrected all values to 348C using
the Einstein relationship, Df(348C)/Df(208C) ¼ [T(348C)/T(208C)] 3
[h(208C)/h(348C)], where T is the temperature in Kelvin and h is the
viscosity of water. This facilitated direct comparison with Db as these
estimates were obtained at 348C.
RESULTS
RNGF conjugate
The RNGF migrated as a single band under SDS-PAGE
analysis of ;13 kD (corresponding to the weight of the
monomeric b-subunit). The native and conjugated NGF both
stimulated neurite outgrowth at levels as low as 10 ng/ml.
Fit of models to experimental data
Hindered diffusion and Db
Fig. 1 B is a representative ﬁt of Eq. 3 to the extracted
intensity data for one of the three lines indicated in Fig. 1 A
for both the initial image analyzed and an image recorded
later in time. In Fig. 1 B the signal to noise appears low
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because the data is from a line of single pixels with only;10
photons per pixel maximum, and less at the edges of the
diffusing spot. The low ﬂuorescence intensity was due to the
imaging depth into the tissue (;200 mm) and the need to be
at low excitation intensities to ensure that photobleaching
was negligible over the course of the repeated scanning.
Although the signal to noise could have been improved by
using longer pixel integration times (pixel integration time
was;6 ms), we were scanning a dispersing sphere of RNGF,
and it was important to ensure that changes in the intensity
proﬁles due to diffusion did not occur substantially while
collecting each individual image (i.e., time point). The
Gaussian distribution of intensity data as a function of posi-
tion both ﬂattens and spreads in time, as would be expected
for point-source diffusion. As the spread of the intensity data
increases, so does the estimate of Si returned by the opti-
mization routine. Fig. 1 C is a least-squared regression ﬁt of
the estimates of S/4 as a function of t. The slope of the
regression ﬁt gives Db directly.
MPFPR and Df
A representative MPFPR trace is shown in Fig. 2 for one of
the RNGF photobleaching experiments. The data represent
10,000 photobleaching-recovery cycles. As mentioned in
Materials and Methods, we used a low concentration of
RNGF (;190 nM) for these studies to conserve protein,
which resulted in reduced signal to noise relative to previous
MPFPR work using more concentrated solutions (Brown
et al., 1999). Although we show normalized data in Fig. 2,
FIGURE 1 (A) Three centerlines constructed through dispersing sphere of
RNGF molecules yield the intensity proﬁles that were ﬁt to Eq. 3 for all
times recorded in the sequence. (B) The data and ﬁt of the intensity proﬁles
are depicted at an initial time (open squares and dashed line, respectively)
and at 42 s later (solid circles and solid line, respectively). (C) The calculated
values of S/4 were plotted as a function of time for all images in the sequence
to extract Db as the slope, indicated as 4.10 3 10
7 cm2/s in this case. The
procedure was repeated for each of the three centerlines depicted in A.
TABLE 1 1/e2 radii (mm) of the two-photon illumination point
spread function calculated for wavelengths and objective
lenses used
Wavelength (nm) NA vxy vz
800 0.28 1.65* 26.7*
850 0.30 0.91 13.2
850 1.2 0.23 0.60
Calculations carried out using the integral representation of Richards and
Wolf (1959).
*The 43 0.28 NA macro lens used in the dextran studies had a 25-mm back
aperture and was underﬁlled (beam diameter was ;10 mm). Calculation
was modiﬁed accordingly to account for the degree of underﬁlling resulting
in values that were ;2 larger than the diffraction limited case.
FIGURE 2 Typical MPFPR curve for RNGF; ﬂuorescence data were
normalized to the average count value before the 10 ms photobleaching pulse
at t¼ 0. Nonlinear ﬁt of the recovery returns a value for Df (208C) of 8.623
107 cm2/s. Excitation and bleaching wavelength was 850 nm delivered
through a 603, 1.2 NA water-immersion objective lens. Average power
during bleaching pulse and monitoring was ;10 mW and ;1 mW,
respectively.
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prebleach count rates were less than 100 KHz. For all of our
measurements, the recovery was well described by a single
coefﬁcient model.
Estimation of D
Table 2 gives a summary of the estimates for Db and Df. For
Df, we report data from 24 photobleaching experiments. For
Db, we include a validation trial with dextran, where we
collected data from two rats, with one coronal section per rat
and a maximum of three injections per slice. The RNGF
study in tissue was more exhaustive and represents data
collected from four rats, with up to two sections per animal
and ﬁve injections per section. In some instances, the injec-
ted amount was barely detectable; this was attributed to
injector clogging, and these data were omitted from further
analysis. In all studies, we generated three replicate estimates
of Db for each injection to give a total of 78 and 15 estimates
of Db for RNGF and dextran, respectively.
For Db and Df, the mean values are greater than median
values for each case, reﬂecting a slight positive skew in the
data. The most likely source of the skew comes from
a restriction on D; negative values of D are not physically
realizable, and the distribution cannot be symmetric about
the mean value (which is close to zero relative to the spread
of the data). Accordingly, we compared means using log(D)
as the independent variable in the model to account for the
log-normal distribution. Results from a Tukey-Kramer
Honestly Signiﬁcant Difference test conﬁrm that all pairs
of our estimates are signiﬁcantly different from one another
(a ¼ 0.05). The previously published Db(348C) estimate for
70 kD dextran in rat cortex, 0.75 3 107 cm2/s (Nicholson
and Tao, 1993), is lower than our estimate in the striatum,
0.843 107 cm2/s, although the literature value is within the
95% conﬁdence interval spanning 0.60–1.08 3 107 cm2/s.
The calculated values for RNGF in brain, 2.753 107 cm2/s,
and in solution, 12.6 3 107 cm2/s, reﬂect the anticipated
hindrance to diffusive transport in tissue.
DISCUSSION
From our previous investigations with long-term delivery to
whole animals, NGF penetration through brain tissue is
spatially restricted (Krewson et al., 1995; Mahoney and
Saltzman, 1999). This earlier work provided motivation
for this study: development and validation of a new method
for estimating diffusion coefﬁcients in brain tissue, and
estimation of transport constants for NGF in free solution
and in brain tissue. To make efﬁcient use of our RNGF
supply, we elected to use an injection, rather than photo-
bleaching procedure to determine Db. In the derivation of
Eq. 4, a uniform initial concentration of ﬂuorophore is as-
sumed and therefore large quantities of RNGF would have to
be loaded into the tissue to achieve this initial condition. The
replicate measurements required to perform statistical testing
would further exacerbate the problem. In contrast, the in-
jection paradigm allowed us to obtain multiple estimates of
Db with nanoliter quantities of material.
Despite differences in methodology and site of adminis-
tration, we note very good agreement between our Db esti-
mate for 70 kD dextran and that from the literature. In our
case, we studied diffusion in the striatum, whereas previous
estimates were obtained with injections to cortical layers III,
V, and VI (Nicholson and Tao, 1993). There is a discrepancy
between t estimates reported for these same cortical layers
(t¼ 1.62–1.65 in 90–120-day-old rats) (Lehmenkuhler et al.,
1993) and the striatum (t ¼ 1.54) (Rice and Nicholson,
1991) with tetramethylammonium diffusion studies. It is
reasonable to assume that domain-speciﬁc variability may
account for some of the difference observed between our
measurement and the previous result. Furthermore, we ﬁt
Eq. 3 directly to our extracted data, whereas literature esti-
mates require further manipulations. Although there are no
general models for prediction of Db, for globular proteins
Df may be regressed upon the inverse cubic root of the
molecular weight (1/M1/3) (Saltzman et al., 1994). We
performed this regression using Df values from the literature
(Sober, 1970), and superimposed our result for RNGF upon
this plot (Fig. 3). Our estimate lies near the regression line
and well within the 95% conﬁdence intervals, lending
credibility to our result.
Whereas simple correlations exist that enable us to pre-
dict Df with some accuracy, the complexities of diffusion in
tissue hamper efforts at a general, predictive model for t.
Nicholson has estimated t in rat brain cortex for albumins
(Tao and Nicholson, 1996), dextrans (Nicholson and
TABLE 2 Moment and parametric data for D (3107 cm2/s)
Species N Mean Standard deviation Median 75% quartile 25% quartile
*RNGF (free) 24 12.6 4.53 12.1 13.6 9.42
RNGF (brain) 78 2.75 2.13 2.14 3.63 1.08
yDextran (brain) 15 0.84 0.43 0.63 1.23 0.50
Dextran (brain, literature) 12 0.75 0.16 – – –
Because the data are log-normal, we evaluated the logarithm of the individual data in a Tukey-Kramer test and determined all our estimates were signiﬁcantly
different from one another.
*Df for RNGF was obtained at 208C, and corrected to 348C via the Einstein relationship.
yResults for 70 kD FITC-dextran conjugate reﬂect measurements in brain tissue only, and are cited for both our study and from a literature source (Nicholson
et al., 1993) (quartile data were not available from the literature for dextran).
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Tao, 1993), poly[N-(2-hydroxypropyl)methacrylamide]
(PHPMA) polymers and a PHPMA-bovine serum albumin
(BSA) conjugate (Prokopova-Kubinova et al., 2001). For
low molecular weight dextrans (3 and 10 kDa) and all of the
PHPMA fractions considered (spanning from 7.8 to 1057
kDa), t ranges from 1.46 to 1.70. The albumins (lactalbumin,
ovalbumin, and BSA) suffer increased hindrance to dif-
fusion, with t values ranging from 2.24 to 2.50. The 70 kD
dextran (postulated to occupy a spherical shape at this size)
and the bulky 176 kD PMMA-BSA conjugate also ex-
perience relatively hampered diffusion, with reported t
values of 2.25 and 2.27, respectively. These ﬁndings led to
the conclusion that diffusion in the ECS of normal brain
tissue is dependent upon molecular conﬁguration; linear
molecules enjoy relative ease in navigating the ECS relative
to more compact spherical or globular molecules. Reports in
the literature conﬁrm this hypothesis across several exper-
imental platforms. Fox and Wayland (1979) noted the
apparent D for rat serum albumin in the rat mesentery is
approximately half that of a dextran with the same hydro-
dynamic radius. Nugent and Jain (1984) reported a similar
disparity in D between BSA and dextrans of comparable size
in both normal and tumor tissue. The authors postulated that
BSA suffers hampered diffusion not only due to molecular
conﬁguration, but also possibly due to like-charge repulsion
(negative charges associated with BSA and components of
the ECM) and binding to tissue.
We calculated a t value of 2.14 for RNGF and compared
our results with previous estimates in normal rat brain tissue
to ascertain the relative ease with which NGF navigated the
interstitium. A k-means clustering analysis partitions the data
into two groups: the ﬁrst spans t ¼ [1.46, 1.70] and includes
all PHPMA and low molecular-weight (3 and 10 kD)
dextrans, whereas the second spans t ¼ [2.14, 2.50] and
includes RNGF, the albumins, and high molecular weight
dextrans (40 and 70 kD) (Fig. 4). The data are partitioned in
the manner anticipated from the previous works in that
compact molecules collectively experience greater hindrance
than their more linear counterparts. Although assigned to the
high-t category, RNGF corresponds to the lowest t of this
group, indicating relatively facile diffusion among its peers.
Of the albumins studied, lactalbumin has the Df (and hence
hydrodynamic radius) closest to RNGF (11.9 (Tao and
Nicholson, 1996) and 12.1 3 107 cm2/s, respectively).
Despite the similarities in size, t for RNGF (2.14) is slightly
less than that reported for lactalbumin (2.24 (Tao and
Nicholson, 1996)). This slightly enhanced diffusion mimics
the general trend noted from our 70 kD dextran control study,
where we note approximately a 12% enhancement in Db
relative to literature values. Like the dextran control, this may
be in part due to site-speciﬁc variability, in that our t estimates
were obtained in the striatum whereas literature values were
measured in the cortex. We did not expect our comparison to
be affected by differences in age between the animals
investigated in our study and those used in the cited literature;
a previous study reported no signiﬁcant effect of rat age upon
t values obtained in cortex and white matter over a span of
2–120 postnatal days (Lehmenkuhler et al., 1993).
We assumed negligible inﬂuence of elimination on the
concentration proﬁles over the time span considered in this
experiment (seconds to minutes). For long-duration studies
(hours and greater), the ﬁnal distribution of NGF in rat brain
tissue is a result of a competition between diffusion and
elimination mechanisms that serve to assist and hamper
transport, respectively (Krewson et al., 1995; Krewson and
Saltzman, 1996). Tissue NGF concentration proﬁles ap-
proach steady-state distributions in the vicinity of controlled-
release polymeric intracranial implants (Mahoney and Saltz-
man, 1996). The steady concentration proﬁle normalized to
the concentration at the controlled release source-tissue inter-
face (Co) is a function of a so-called eliminationmodulus, (f).
The modulus is in turn a function of Db, a ﬁrst-order
elimination constant ke, and the polymer half-width a
(Radomsky et al., 1990):
FIGURE 3 Various literature estimates (circles) of Df (310
7 cm2/s) for
globular proteins (Sober, 1970) at 208C regressed upon M1/3. Solid and
dashed lines indicate regression ﬁt and 95% individual conﬁdence bands,
respectively. Our superimposed estimate of Df (208C) for RNGF (star), lies
near the regression ﬁt and well within the conﬁdence intervals, indicating
our estimate is within the expected range.
FIGURE 4 Results from a k-means clustering analysis partitions t values
into two groups characterized by comparatively high- and low-t values; our
estimate of t for RNGF is the lowest among the high-t group, comprised of
albumins and high molecular weight dextrans. From this analysis, RNGF
experienced only intermediate difﬁculty in navigating the striatum.
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The elimination constant, ke, is a lumped parameter that
accounts for all mechanisms that may serve to clear the
molecule from the brain, including degradation and blood-
brain barrier permeation. From previous studies, NGF
concentration proﬁles are characterized by a modulus value
of approximately unity, which corresponds to very limited
(2–3 mm) penetration of factor into surrounding tissue
(Krewson and Saltzman, 1996). The modulus value is the
lone ﬁtted parameter from steady proﬁles; we consequently
only learn the ratio of ke to Db, not the individual values of
these parameters. We cannot be certain if abnormally slow
diffusion or rapid elimination is the source of limited NGF
penetration from steady-state proﬁles. With our independent
estimate of Db and historical values for f, we calculated
a value for ke of 0.01/min, corresponding to an elimination
half-life (t1/2) of 1.2 h. Comparison of characteristic times for
diffusion (td) and elimination allows us to unlock the
therapeutic potential of NGF through rational formulation
design (Haller and Saltzman, 1998). We deﬁne td as the ratio
of the square of a characteristic length to Db. Tissue
penetration of NGF surrounding an implant is on the order of
1 mm (Krewson and Saltzman, 1996); using 1 mm as the
characteristic length, we calculated a td of ;10 h. The
elimination process, characterized by t1/2 ¼ 1.2 h, is rapid
relative to diffusion over this length scale, suggesting one
must circumvent this rapid elimination mechanism to extend
the therapeutic reach of NGF in diseased brain tissue
(Belcheva et al., 1999; Krewson et al., 1996).
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